Cargando…

The Use of In Silico Tools for the Toxicity Prediction of Potential Inhibitors of SARS-CoV-2

The current strategy for treating the Covid-19 coronavirus disease involves the repurposing of existing drugs or the use of convalescent plasma therapy, as no specific therapeutic intervention has yet received regulatory approval. However, severe adverse effects have been reported for some of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat, Varsha, Chatterjee, Jhinuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047515/ https://www.ncbi.nlm.nih.gov/pubmed/33845649 http://dx.doi.org/10.1177/02611929211008196

Ejemplares similares

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022)

In-silico design of a potential inhibitor of SARS-CoV-2 S protein
por: Jaiswal, Grijesh, et al.
Publicado: (2020)

In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2
por: Laurie, Kyle, et al.
Publicado: (2021)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors
por: Elseginy, Samia A., et al.
Publicado: (2021)

SARS-CoV-2 Papain-Like Protease Potential Inhibitors—In Silico Quantitative Assessment
por: Stasiulewicz, Adam, et al.
Publicado: (2021)

Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

Lingonberry polyphenols: Potential SARS‐CoV‐2 inhibitors as nutraceutical tools?
por: Pärnänen, Pirjo, et al.
Publicado: (2021)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)

In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2023)

In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
por: Hossain, Rajib, et al.
Publicado: (2021)

In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
por: Huynh, Tien, et al.
Publicado: (2021)

In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
por: Cetin, Adnan
Publicado: (2021)

Correction to: Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
por: Kumar, Yogesh, et al.
Publicado: (2020)

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
por: Mohamed, Eslam A. R., et al.
Publicado: (2023)

Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study
por: Borquaye, Lawrence Sheringham, et al.
Publicado: (2020)

In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection
por: Vivek-Ananth, R.P., et al.
Publicado: (2020)

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
por: Falade, Victoria Adeola, et al.
Publicado: (2021)

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing
por: Tristán-Flores, Fabiola E, et al.
Publicado: (2021)

Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies
por: Sethi, Aaftaab, et al.
Publicado: (2020)

Design, synthesis and in silico screening of benzoxazole–thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases
por: Krishna Cheerala, Vijay Sai, et al.
Publicado: (2021)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein
por: Jalily, Pouria H., et al.
Publicado: (2022)

Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach
por: Avelar, Mayra, et al.
Publicado: (2023)

Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
por: Lopes, Alberto Jorge Oliveira, et al.
Publicado: (2022)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2022)

Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
por: Abel, Renata, et al.
Publicado: (2020)

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
por: Rangsinth, Panthakarn, et al.
Publicado: (2021)

In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets
por: Duru, Chidi Edbert, et al.
Publicado: (2021)

An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2
por: Shakhsi-Niaei, Mostafa, et al.
Publicado: (2021)

In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection
por: Ahmadi, Amirhossein, et al.
Publicado: (2021)

In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors
por: Singh, Rahul, et al.
Publicado: (2021)

Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling
por: Al-Sanea, Mohammad M., et al.
Publicado: (2021)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
por: Afreen, Rukhsar, et al.
Publicado: (2022)

In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes
por: Alanzi, Abdullah R, et al.
Publicado: (2023)

In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction
por: Silva-Arrieta, Sandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dg822fnt6ajsdc5snelautum5j